IS6649A - Agnasamsetning af eletriptani sem sýnir s-laga mynstur af stýrðri losun - Google Patents

Agnasamsetning af eletriptani sem sýnir s-laga mynstur af stýrðri losun

Info

Publication number: IS6649A
Authority: IS; Iceland
Prior art keywords: eletriptan; showing; controlled release; shaped pattern; particle composition
Prior art date: 2000-08-02

Application number

IS6649A

Other languages

English (en)

Inventor

Pierre Frederic De Raspide Manaud

James Macrae Ross

Walther Mathias

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-02

Filing date

2002-12-05

Publication date

2002-12-05

2002-12-05 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2002-12-05 Publication of IS6649A publication Critical patent/IS6649A/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Electroluminescent Light Sources (AREA)
Luminescent Compositions (AREA)

IS6649A 2000-08-02 2002-12-05 Agnasamsetning af eletriptani sem sýnir s-laga mynstur af stýrðri losun IS6649A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0018968.8A GB0018968D0 (en)	2000-08-02	2000-08-02	Particulate composition
PCT/IB2001/001279 WO2002009675A1 (en)	2000-08-02	2001-07-18	Particulate composition of eletriptan showing a sigmoidal pattern of controlled release

Publications (1)

Publication Number	Publication Date
IS6649A true IS6649A (is)	2002-12-05

Family

ID=9896843

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6649A IS6649A (is)	2000-08-02	2002-12-05	Agnasamsetning af eletriptani sem sýnir s-laga mynstur af stýrðri losun

Country Status (38)

Country	Link
US (1)	US20020034545A1 (is)
EP (1)	EP1365748B1 (is)
JP (1)	JP2004505034A (is)
KR (1)	KR20030024820A (is)
CN (1)	CN1630511A (is)
AP (1)	AP2001002233A0 (is)
AR (1)	AR030099A1 (is)
AT (1)	ATE308978T1 (is)
AU (1)	AU2001270932A1 (is)
BG (1)	BG107361A (is)
BR (1)	BR0112839A (is)
CA (1)	CA2417887C (is)
CZ (1)	CZ2003241A3 (is)
DE (1)	DE60114887T2 (is)
EA (1)	EA200300110A1 (is)
EC (1)	ECSP034451A (is)
EE (1)	EE200300051A (is)
ES (1)	ES2250429T3 (is)
GB (1)	GB0018968D0 (is)
GT (1)	GT200100149A (is)
HR (1)	HRP20030036A2 (is)
HU (1)	HUP0301453A2 (is)
IL (1)	IL153494A0 (is)
IS (1)	IS6649A (is)
MA (1)	MA26934A1 (is)
MX (1)	MXPA03000999A (is)
NO (1)	NO20030498D0 (is)
NZ (1)	NZ522976A (is)
OA (1)	OA12348A (is)
PA (1)	PA8523101A1 (is)
PE (1)	PE20020385A1 (is)
PL (1)	PL359847A1 (is)
SK (1)	SK1082003A3 (is)
SV (1)	SV2002000574A (is)
TN (1)	TNSN01115A1 (is)
UY (1)	UY26861A1 (is)
WO (1)	WO2002009675A1 (is)
ZA (1)	ZA200300868B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040022853A1 (en) *	2001-04-26	2004-02-05	Control Delivery Systems, Inc.	Polymer-based, sustained release drug delivery system
US20060134012A1 (en) *	2002-12-16	2006-06-22	Symington John M	Temporary pharmacologically-inactive dental coating for the in situ protection of dental therapeutic agents from saliva and abrasion from chewing
WO2004089365A1 (en)	2003-04-11	2004-10-21	Pfizer Limited	Pharmaceutical combination comprising eletriptan and sodium bicarbonate
GB2407498B (en) *	2003-10-30	2008-06-11	Cipla Ltd	Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
WO2005120456A2 (en) *	2004-06-09	2005-12-22	Pfizer Limited	Formulation of eletriptan
WO2006013431A1 (en) *	2004-07-29	2006-02-09	Pfizer Limited	Stable controlled-release pharmaceutical formulation of eletriptan
WO2006080481A1 (ja) *	2005-01-31	2006-08-03	Kyorin Pharmaceutical Co., Ltd.	マルチプルユニット型経口徐放性製剤及びその製造方法
WO2007016948A1 (de)	2005-08-10	2007-02-15	Add Advanced Drug Delivery Technologies Ltd.	Orales präparat mit kontrollierter freisetzung
US20070134322A1 (en) *	2005-12-14	2007-06-14	Forest Laboratories, Inc.	Modified and pulsatile release pharmaceutical formulations of escitalopram
US7722898B2 (en)	2006-04-26	2010-05-25	Supernus Pharmaceuticals, Inc.	Modified-release preparations containing oxcarbazepine and derivatives thereof
US20080226715A1 (en) *	2007-03-16	2008-09-18	Albert Cha	Therapeutic compositions and methods
KR20100056479A (ko)	2007-07-25	2010-05-27	바이오렉스 쎄라퓨틱스, 인코포레이티드	제어 방출 인터페론 약물 제품 및 이를 사용한 ｈｃｖ 감염의 치료
CA2780948C (en) *	2009-11-16	2017-06-27	Evonik Roehm Gmbh	A process for converting a solid (meth)acrylate copolymer into a dispersed form by means of a dispersing agent
FR3025425A1 (fr) *	2014-09-09	2016-03-11	Charleston Lab Inc	Compositions pharmaceutiques
GB201716716D0 (en) *	2017-10-12	2017-11-29	Univ Of Hertfordshire Higher Education Corporation	Method for coating particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2624732B1 (fr) *	1987-12-21	1991-02-15	Synthelabo	Formulation pharmaceutique a liberation prolongee
US5411745A (en) *	1994-05-25	1995-05-02	Euro-Celtique, S.A.	Powder-layered morphine sulfate formulations
GB9417310D0 (en) *	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents
GB9825988D0 (en) *	1998-11-27	1999-01-20	Pfizer Ltd	Indole derivatives
GB9922963D0 (en) *	1999-09-28	1999-12-01	Pfizer Ltd	Polymorphic salt
FR2795962B1 (fr) *	1999-07-08	2003-05-09	Prographarm Laboratoires	Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20020044962A1 (en) *	2000-06-06	2002-04-18	Cherukuri S. Rao	Encapsulation products for controlled or extended release

2000
- 2000-08-02 GB GBGB0018968.8A patent/GB0018968D0/en not_active Ceased
2001
- 2001-07-18 EP EP01949819A patent/EP1365748B1/en not_active Expired - Lifetime
- 2001-07-18 MX MXPA03000999A patent/MXPA03000999A/es active IP Right Grant
- 2001-07-18 AP APAP/P/2001/002233A patent/AP2001002233A0/en unknown
- 2001-07-18 OA OA1200300020A patent/OA12348A/en unknown
- 2001-07-18 AT AT01949819T patent/ATE308978T1/de not_active IP Right Cessation
- 2001-07-18 JP JP2002515228A patent/JP2004505034A/ja active Pending
- 2001-07-18 EA EA200300110A patent/EA200300110A1/ru unknown
- 2001-07-18 CZ CZ2003241A patent/CZ2003241A3/cs unknown
- 2001-07-18 DE DE60114887T patent/DE60114887T2/de not_active Expired - Lifetime
- 2001-07-18 KR KR10-2003-7001402A patent/KR20030024820A/ko not_active Ceased
- 2001-07-18 HR HR20030036A patent/HRP20030036A2/hr not_active Application Discontinuation
- 2001-07-18 WO PCT/IB2001/001279 patent/WO2002009675A1/en not_active Ceased
- 2001-07-18 SK SK108-2003A patent/SK1082003A3/sk not_active Application Discontinuation
- 2001-07-18 AU AU2001270932A patent/AU2001270932A1/en not_active Abandoned
- 2001-07-18 BR BR0112839-6A patent/BR0112839A/pt not_active Application Discontinuation
- 2001-07-18 PL PL35984701A patent/PL359847A1/xx not_active Application Discontinuation
- 2001-07-18 HU HU0301453A patent/HUP0301453A2/hu unknown
- 2001-07-18 EE EEP200300051A patent/EE200300051A/xx unknown
- 2001-07-18 CN CNA018134041A patent/CN1630511A/zh active Pending
- 2001-07-18 NZ NZ522976A patent/NZ522976A/en unknown
- 2001-07-18 IL IL15349401A patent/IL153494A0/xx unknown
- 2001-07-18 ES ES01949819T patent/ES2250429T3/es not_active Expired - Lifetime
- 2001-07-18 CA CA002417887A patent/CA2417887C/en not_active Expired - Fee Related
- 2001-07-25 GT GT200100149A patent/GT200100149A/es unknown
- 2001-07-25 PA PA20018523101A patent/PA8523101A1/es unknown
- 2001-07-25 US US09/912,774 patent/US20020034545A1/en not_active Abandoned
- 2001-07-30 SV SV2001000574A patent/SV2002000574A/es not_active Application Discontinuation
- 2001-07-30 UY UY26861A patent/UY26861A1/es not_active Application Discontinuation
- 2001-08-01 PE PE2001000770A patent/PE20020385A1/es not_active Application Discontinuation
- 2001-08-01 TN TNTNSN01115A patent/TNSN01115A1/fr unknown
- 2001-08-01 AR ARP010103668A patent/AR030099A1/es unknown
2002
- 2002-12-05 IS IS6649A patent/IS6649A/is unknown
- 2002-12-06 BG BG107361A patent/BG107361A/bg unknown
2003
- 2003-01-23 MA MA27009A patent/MA26934A1/fr unknown
- 2003-01-24 EC EC2003004451A patent/ECSP034451A/es unknown
- 2003-01-31 ZA ZA200300868A patent/ZA200300868B/en unknown
- 2003-01-31 NO NO20030498A patent/NO20030498D0/no unknown

Also Published As

Publication number	Publication date
BG107361A (bg)	2003-06-30
MXPA03000999A (es)	2003-06-09
US20020034545A1 (en)	2002-03-21
OA12348A (en)	2004-03-19
CZ2003241A3 (cs)	2004-02-18
UY26861A1 (es)	2002-02-28
EA200300110A1 (ru)	2003-06-26
EE200300051A (et)	2004-10-15
EP1365748B1 (en)	2005-11-09
WO2002009675A1 (en)	2002-02-07
SK1082003A3 (en)	2004-09-08
ECSP034451A (es)	2003-03-10
ZA200300868B (en)	2004-04-16
AU2001270932A1 (en)	2002-02-13
ATE308978T1 (de)	2005-11-15
DE60114887T2 (de)	2006-07-20
HRP20030036A2 (en)	2003-04-30
TNSN01115A1 (fr)	2005-11-10
PE20020385A1 (es)	2002-05-11
JP2004505034A (ja)	2004-02-19
GB0018968D0 (en)	2000-09-20
CA2417887C (en)	2006-11-14
AR030099A1 (es)	2003-08-13
KR20030024820A (ko)	2003-03-26
PA8523101A1 (es)	2002-08-26
CA2417887A1 (en)	2002-02-07
GT200100149A (es)	2002-06-25
EP1365748A2 (en)	2003-12-03
PL359847A1 (pl)	2004-09-06
CN1630511A (zh)	2005-06-22
NZ522976A (en)	2004-11-26
WO2002009675A9 (en)	2003-09-18
NO20030498L (no)	2003-01-31
BR0112839A (pt)	2003-06-24
MA26934A1 (fr)	2004-12-20
SV2002000574A (es)	2002-12-02
IL153494A0 (en)	2003-07-06
DE60114887D1 (de)	2005-12-15
HUP0301453A2 (hu)	2003-08-28
ES2250429T3 (es)	2006-04-16
NO20030498D0 (no)	2003-01-31
AP2001002233A0 (en)	2001-09-30

Publication	Publication Date	Title
IS6649A (is)	2002-12-05	Agnasamsetning af eletriptani sem sýnir s-laga mynstur af stýrðri losun
EP1126826A4 (en)	2004-05-06	MULTIPARTIC COMPOSITION WITH MODIFIED RELEASE
EP1125586A4 (en)	2003-06-11	EXTENDED RELEASE PARTICLE
AU6317001A (en)	2001-11-26	Spontaneous pattern formation of functional materials
DK1064942T3 (da)	2004-11-01	Sustained release-fremstilling af et makrolid
DK1296656T3 (da)	2006-11-27	Fremgangsmåde til fremstilling af et præparat
NO20012857D0 (no)	2001-06-08	Galantaminsammensetning med kontrollert frigivelse
ATE376582T1 (de)	2007-11-15	Zusammensetzungen mit photolabilen parfümfreisetzungssystemen
DE60103582D1 (de)	2004-07-08	Zusammensetzungen mit kontrollierter Freisetzung
IS5254A (is)	1999-11-18	Samsetning sem inniheldur fíngerðar, kristallaðaragnir af búdesóníð
DK1674084T3 (da)	2009-12-14	Forlænget frigivelse af oral dosissammensætning
NO20031317L (no)	2003-05-21	Sammensetning av overflateaktivt stoff for gipspussplater
DE60041428D1 (de)	2009-03-12	Neue Esterverbindungen, Polymere, Resistzusammensetzungen und Strukturierungsverfahren
NO20021540D0 (no)	2002-03-27	Sammensetninger med kontrollert frigivelse omfattende nimesulfid
DK1353994T3 (da)	2013-10-21	Modificerede uorganiske partikler
DE60233406D1 (de)	2009-10-01	Fotoresist-entfernungszusammensetzung
FR2812541B1 (fr)	2003-07-04	Prothese unicompartimentale du genou
DE69928892D1 (de)	2006-01-19	Zusammensetzung einer biologisch abbaubaren mineralwolle
DE60122229D1 (de)	2006-09-28	Trennfilm
DE60039274D1 (de)	2008-08-07	Negativ arbeitende Resistzusammensetzung
EP1283701A4 (en)	2004-03-17	A COATING COMPOSITION TO EASIER CONTROLLED RELEASE
HUP0204417A3 (en)	2005-03-29	Oral ciprofloxacin-composition of controlled release
DE60135023D1 (de)	2008-09-04	Trennmittelzusammensetzung
DE60127021D1 (de)	2007-04-19	Esterverbindungen, Polymere, Photoresistkompositionen und Mustererzeugungsverfahren
NO20005313L (no)	2000-11-21	Perforale sammensetninger av levosimendan med kontrollert frigjöring